Welcome to Phoenix Rising!
Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.
To become a member, simply click the Register button at the top right.
Great! I hope you continue to feel better.
Love is...making homemade suppositories for your OH?! Or, trusting your OH to do that?!
Guys I didn't create this thread for what you're discussing. Maybe it'd be better if you created a CBD usage thread, don't you think? This is a thread for the role of the endocannabinoid system in the general CFSME patophysiology, mostly in a biochemical way.
Fun if you're in the US ?I did some searching and the FDA has recently approved cannabis derived CBD under brand name Epidiolex. It is approved for epilepsy, but I believe drugs can be prescribed for other uses.
The only remaining issue is the DEA. Since Epidiolex is derived from cannabis and not synthesized I'm reading that cannabis has to be rescheduled to either level 2 or 3. The DEA has about 3 months to do that as of June, 25.
Once that happens it should be fairly easy to obtain. I'm still not sure if I want to take it though just because I really want to get to the bottom of this and don't want to mess up my system. It may help alleviate some of the fatigue and other symptoms though.
It also looks like there is a bill that will be amending the controlled substance act to follow the tenth amendment of the federal constitution when it comes to marihuana specifically. It says that the federal ban on marihuana shall not apply to persons who are compliance with state law. So the federal government will not be legalizing marijuana or prohibiting it, but finally merely leaving it up to the state law in law, rather than simply by lack of enforcement of federal law. This is what always should have been done anyway, because it creates a horrible mess to have a law on the books that is not enforced sometimes as a matter of policy but to not repeal that law.
[T]he objective of the current article is (i) to summarize the most recent findings of the field; (ii) to highlight the putative therapeutic potential of targeting cannabinoid signaling; (iii) to identify open questions and key challenges; and (iv) to suggest promising future directions for cannabinoid-based drug development.